Top compounds associated with response to RBM20


Feature Type Standardized
Nominal ANOVA
mRNA RAF265 CTRPv2 pan-cancer AAC 0.019 0.7
mRNA Crizotinib gCSI pan-cancer AAC 0.025 0.7
mRNA YK 4-279 GDSC1000 pan-cancer AAC 0.017 0.7
mRNA prochlorperazine CTRPv2 pan-cancer AAC -0.017 0.7
mRNA tandutinib CTRPv2 pan-cancer AAC -0.016 0.7
mRNA BRD-A94377914 CTRPv2 pan-cancer AAC -0.021 0.7
mRNA LFM-A13 GDSC1000 pan-cancer AAC -0.016 0.7
mRNA cediranib CTRPv2 pan-cancer AAC -0.023 0.7
mRNA Ki8751 CTRPv2 pan-cancer AAC -0.016 0.7
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.015 0.7
Download CSV